Abstract

Di- and triorganotin(IV) derivatives of tyrosylalanine (H2Tyr-Ala) with general formula R2Sn(Tyr-Ala) (where R = Me, n-Bu, n-Oct, and Ph) and R3Sn(HTyr-Ala) (where R = Me and Ph) have been synthesized and structurally characterized in the solid state as well as in solution on the basis of various spectroscopic techniques, namely. FT-IR, multinuclear (1H, 13C and 119Sn) NMR and 119Sn Mössbauer. These investigations suggest that tyrosylalanine in R2Sn(Tyr-Ala) acts as dianionic tridentate ligand coordinating through carboxylate oxygen [–C(O)O−], amino (–NH2), and (CO)Npeptide- nitrogen, while in the case of R3Sn(HTyr-Ala), the ligand acts as monoanionic bidentate coordinating through –C(O)O− and –NH2, and the polyhedron around tin in R2Sn(Tyr-Ala) and R3Sn(HTyr-Ala) is a distorted trigonal-bipyramidal. Equilibrium (pH-metric) studies of the interaction of Me2Sn(IV)2+ and Me3Sn(IV)+ with dipeptides namely, tyrosylalanine (H2Tyr-Ala), glycyltyrosine (H2Gly-Tyr), and glycylisoleucine (H2Gly-Ile), in aqueous solution (I = 0.1 M KNO3, 298 K) have also been carried out. The concentration distribution of the various complex species in solution has been evaluated as a function of pH. It has been found that in these dipeptides, [–C(O)O−, N−, NH2] coordinated complexes are dominant in the neutral pH range with a trigonal-bipyramidal structure. The complex species formed are water soluble in the pH range 2.7–10.5. In all of the studied systems, no polymeric species have been detected in the experimental pH range. Beyond pH 8.0, significant amounts of hydroxo species, namely. Me3Sn(OH) and Me2Sn(OH)2, are formed.

Highlights

  • Organotin compounds have emerged as potential future pharmaceuticals as antitumor agents among nonplatinum chemotherapeutic metallopharmaceuticals in the last two decades [1,2,3,4,5]

  • We report the synthesis and structural studies of di- and triorganotin(IV) derivatives of tyrosylalanine (H2Tyr-Ala)

  • A distorted trigonalbipyramidal structure is proposed for the synthesized diand triorganotin(IV) tyrosylalaninates in the solid state on the basis of the results obtained from the spectroscopic techniques used

Read more

Summary

Introduction

Organotin compounds have emerged as potential future pharmaceuticals as antitumor agents among nonplatinum chemotherapeutic metallopharmaceuticals in the last two decades [1,2,3,4,5]. Organotin(IV) tyrosylalaninates, some bands in region 3427– 3055 cm−1 undergo substantial lowering when compared with H2Tyr-Ala (3440–3180 cm−1), indicating the participation of amino group in coordination to tin.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call